Spots Global Cancer Trial Database for epithelial mesothelioma
Every month we try and update this database with for epithelial mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | NCT00003723 | Malignant Mesot... | gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | NCT00066651 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma | NCT01105390 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | rilotumumab cisplatin pemetrexed diso... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00227630 | Malignant Mesot... | cisplatin pemetrexed diso... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gefitinib in Treating Patients With Malignant Mesothelioma | NCT00025207 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | gefitinib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery | NCT00003723 | Malignant Mesot... | gemcitabine hyd... | 18 Years - | SWOG Cancer Research Network | |
| Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 | NCT00898547 | Malignant Mesot... | immunoenzyme te... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma | NCT00054002 | Malignant Mesot... | adjuvant therap... conventional su... porfimer sodium | 18 Years - | Roswell Park Cancer Institute | |
| S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery | NCT00243074 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | cediranib malea... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00309946 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | cediranib malea... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00334594 | Malignant Mesot... | Cisplatin Pemetrexed Therapeutic con... Radiotherapy | 18 Years - 69 Years | Swiss Group for Clinical Cancer Research | |
| Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma | NCT00821860 | Malignant Mesot... Metastatic Canc... | talc therapeutic tho... therapeutic vid... | 18 Years - | Papworth Hospital NHS Foundation Trust | |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma | NCT00354393 | Malignant Mesot... | Cisplatin Methotrexate Vinorelbine dit... Adjuvant therap... Conventional su... Neoadjuvant The... 3-dimensional c... Intensity-modul... | - 75 Years | The Cleveland Clinic | |
| Capecitabine in Treating Patients With Malignant Mesothelioma | NCT00004183 | Malignant Mesot... | capecitabine | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung | NCT00039182 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | erlotinib hydro... laboratory biom... | - | National Cancer Institute (NCI) | |
| Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00075699 | Malignant Mesot... | cisplatin mitomycin C vincristine sul... vinorelbine tar... pain therapy psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery | NCT00365053 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | belinostat laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma | NCT00027703 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | gemcitabine hyd... cisplatin bevacizumab placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery | NCT00309946 | Advanced Malign... Epithelial Meso... Localized Malig... Recurrent Malig... Sarcomatous Mes... | cediranib malea... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. | NCT00107432 | Epithelial Meso... Recurrent Malig... Sarcomatous Mes... Stage IA Malign... Stage IB Malign... Stage II Malign... Stage III Malig... Stage IV Malign... | sorafenib tosyl... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy | NCT01085630 | Malignant Mesot... | pemetrexed diso... clinical observ... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma | NCT01105390 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | rilotumumab cisplatin pemetrexed diso... laboratory biom... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
